RecruitingPhase 4NCT06269770

Tapentadol vs Tramadol in Total Knee Arthroplasty

Multimodal Analgesia in TKA. The Role of Tapentadol


Sponsor

University of Thessaly

Enrollment

96 participants

Start Date

May 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Compare the effectiveness of tapentadol and tramadol as part of a multimodal analgesia treatment for Total Knee Replacement (TKR).


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria2

  • Patients for elective TKR
  • ASA PS I - III

Exclusion Criteria12

  • Patient refusal
  • Cognitive disfunction
  • Severe psychiatric disease
  • Under medication with MAO inhibitors, tricyclic antidepressants, serotonin reuptake inhibitors
  • Not speaking Greek
  • Known allergy to the study drugs
  • Contraindications for any of the study drugs
  • Chronic renal failure (GFR \< 50 ml/h)
  • Liver failure
  • Known regular use or misuse of opioids
  • Pregnant women
  • Patients undergoing general anesthesia

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGTapentadol

Add tapentadol, for effective pain management in a multimodal setting during TKR.

DRUGTramadol

Add tramadol, for effective pain management in a multimodal setting during TKR.


Locations(1)

University Hospital Of Larissa

Larissa, Thessaly, Greece

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06269770


Related Trials